am 251 has been researched along with Colitis Gravis in 1 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sałaga, M | 1 |
| Mokrowiecka, A | 1 |
| Zakrzewski, PK | 1 |
| Cygankiewicz, A | 1 |
| Leishman, E | 1 |
| Sobczak, M | 1 |
| Zatorski, H | 1 |
| Małecka-Panas, E | 1 |
| Kordek, R | 1 |
| Storr, M | 1 |
| Krajewska, WM | 1 |
| Bradshaw, HB | 1 |
| Fichna, J | 1 |
1 other study available for am 251 and Colitis Gravis
| Article | Year |
|---|---|
Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).
Topics: Amidohydrolases; Animals; Cannabinoids; Colitis, Ulcerative; Disease Models, Animal; Dose-Response R | 2014 |